N,N-Dinitrosopentamethylenetetramine
Methenamine, also known as hexamethylenetetramine, has several medical uses primarily related to its antibacterial properties, specifically in the urinary tract. Such as Urinary Tract Infections (UTIs), Methenamine is used prophylactically to prevent recurrent urinary tract infections. When ingested, it is converted in the acidic environment of the bladder into formaldehyde and ammonia, which are bactericidal and help reduce bacterial growth in the urine.
Methenamine Nitroso amine Impurity-2 CAS NO: 101-25-7, also known as Methenamine Hippurate Nitroso amine Impurity-2 or Dinitrosopentamethylenetetramine is chemically identified as 3,7-Dinitroso-1,3,5,7-tetrazabicyclo[3.3.1]nonane,Synchemia Research chemical provide Methenamine Nitroso amine Impurity-2 CAS NO: 101-25-7, also known as Methenamine Hippurate Nitroso amine Impurity-2 or Dinitrosopentamethylenetetramine with comprehensive characterization data that adheres to regulatory guidelines, ensuring its suitability for pharmaceutical applications
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143778 |
| CAS No | 69340-07-4 |
| Mol.F. | C4D8N4O2 |
| Mol.Wt. | 152.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143779 |
| CAS No | NA |
| Mol.F. | C13H17N3O2 |
| Mol.Wt. | 247.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143780 |
| CAS No | 61578-30-1 |
| Mol.F. | C4H4D4N2O2 |
| Mol.Wt. | 120.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143781 |
| CAS No | NA |
| Mol.F. | C613CH13D3N2O6 |
| Mol.Wt. | 228.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143782 |
| CAS No | NA |
| Mol.F. | C7H13D3N2O6 |
| Mol.Wt. | 227.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143783 |
| CAS No | NA |
| Mol.F. | C614CH16N2O6 |
| Mol.Wt. | 226.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143784 |
| CAS No | 2124271-47-0 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143785 |
| CAS No | NA |
| Mol.F. | C22H20D4F2N2O5 |
| Mol.Wt. | 438.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143786 |
| CAS No | 2747915-48-4 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143787 |
| CAS No | NA |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143788 |
| CAS No | 1219166-00-3 |
| Mol.F. | C22H17D8F2NO4 |
| Mol.Wt. | 413.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143789 |
| CAS No | NA |
| Mol.F. | C28H25N5O4 |
| Mol.Wt. | 495.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143790 |
| CAS No | NA |
| Mol.F. | C17H24N2O4 |
| Mol.Wt. | 320.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143791 |
| CAS No | NA |
| Mol.F. | C13H13N3O6 : 2(Na) |
| Mol.Wt. | 307.3 : 2(23.0) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143792 |
| CAS No | 19023-40-6 |
| Mol.F. | C12H15F3N2O |
| Mol.Wt. | 260.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143793 |
| CAS No | NA |
| Mol.F. | C16H22N2O4 |
| Mol.Wt. | 306.36 g/mole |
| INV STATUS | UNDER SYNTHESIS |